Drug Trial Radar · NCT02284516
A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)
Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
711
Actual
Start
Nov 6, 2014
Primary completion
Oct 5, 2015
Study completion Oct 5, 2015
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- Nov 6, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the efficacy and safety of Lifitegrast in subjects with dry eye disease and a recent history of artificial tear use.
Conditions
- Dry Eye Disease
Interventions
LifitegrastDrug
Lifitegrast Ophthalmic Solution 5%, BID for 84 days
PlaceboDrug
Placebo to match active treatment, BID for 84 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Patient-Reported Eye Dryness Score to Day 84Time frame: Baseline to Day 84
Locations
41 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama at Birmingham, UAB School of Optometry
Birmingham, Alabama
Arizona Eye Center
Chandler, Arizona
Sall Research Medical Center
Artesia, California
United Medical Research Institute
Inglewood, California
North Valley Eye Medical Group, Inc
Mission Hills, California
Montebello Medical Eye Center, Inc.
Montebello, California
Eye Research Foundation
Newport Beach, California
Arch Health Partners
Poway, California
Martel Eye Medical Group
Rancho Cordova, California
Shasta Eye Medical Group, Inc.
Redding, California
West Coast Eye Care Associates
San Diego, California
Chicago Cornea Consultants, Ltd.
Hoffman Estates, Illinois
Jackson Eye, SC
Lake Villa, Illinois
Price Vision Group
Indianapolis, Indiana
John-Kenyon American Eye Institute
New Albany, Indiana
Koffler Vision Group
Lexington, Kentucky
The Eye Care Institute
Louisville, Kentucky
Holpro Vision, Ltd.
Union, Kentucky
Clinical Eye Research of Boston
Winchester, Massachusetts
Lifelong Vision Foundation
Chesterfield, Missouri
Tauber Eye Center
Kansas City, Missouri
Tekwani Vision Center
St Louis, Missouri
Ophthalmology Consultants, Ltd.
St Louis, Missouri
Comprehensive Eye Care, Ltd.
Washington, Missouri
Wellish Vision Institute
Las Vegas, Nevada
Abrams Eye Institute
Las Vegas, Nevada
Clinical Vision Research Center at SUNY
New York, New York
Ophthalmic Consultants Of Long Island
Rockville Centre, New York
South Shore Eye Care, LLP
Wantagh, New York
Abrams Eye Center
Cleveland, Ohio
Scott & Christie and Associates, PC
Cranberry Township, Pennsylvania
Matossian Eye Associates
Doylestown, Pennsylvania
Toyos Clinic
Nashville, Tennessee
The Cataract & Glaucoma Center
El Paso, Texas
Advanced Laser Vision and Surgical Institute
Houston, Texas
Whitsett Vision Group
Houston, Texas
University of Houston College of Optometry
Houston, Texas
The Eye Clinic of Texas (Houston Eye Associates)
League City, Texas
Eye Clinics of South Texas, P.A.
San Antonio, Texas
R and R Eye Research, LLC.
San Antonio, Texas
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.